Corpus Intelligence IC Memo — PARIS REGIONAL MEDICAL CENTER 2026-04-26 23:28 UTC
IC Memo — PARIS REGIONAL MEDICAL CENTER
Investment Committee Memorandum | TX | 131 beds | Grade C | EBITDA uplift $9.6M
🛡️ Public data only — no PHI permitted on this instance.
INVESTMENT COMMITTEE MEMORANDUM  ·  CCN 450196

PARIS REGIONAL MEDICAL CENTER

LOCATIONLAMAR, TX·BEDS131·AS OFApril 26, 2026
C
INVESTABILITY
EBITDA BridgeData Room

1. Target Overview & Investment Thesis

PARIS REGIONAL MEDICAL CENTER is a 131-bed suburban community hospital in LAMAR, TX with $131.0M in net patient revenue and a 4.8% operating margin. The hospital serves a payer mix of 39.8% Medicare, 0.5% Medicaid, and 59.7% commercial.

Thesis: Undervalued. Our ML models identify $9.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 4.8% to 12.2% (+736bps).

Net Revenue HCRIS$131.0M
Current EBITDA COMPUTED$6.3M
Operating Margin COMPUTED4.8%
Occupancy HCRIS49.2%
Revenue / Bed COMPUTED$1.0M
Net-to-Gross HCRIS20.8%
Distress Probability ML47.3%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
173
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 4.8% places it above the state median. Among 173 size-comparable peers (66-262 beds), the median margin is 2.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (66-262), prioritizing same-state peers. 173 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PARIS REGIONAL MEDICAL CENTER (Target)TX131$131.0M4.8%
DELL CHILDRENS MEDICAL CENTERTX262$901.9M25.5%
DRISCOLL CHILDRENS HOSPITALTX215$694.3M29.4%
ROUND ROCK HOSPITALTX165$681.4M8.7%
HILLCREST BAPTIST MEDICAL CENTTX236$464.8M-6.7%
THE HEART HOSPITAL BAYLOR PLANTX109$464.6M25.7%
METHODIST RICHARDSON MEDICAL CTX247$449.2M14.6%
DELL SETON MEDICAL CENTER AT TTX225$438.6M-4.2%
WOMANS HOSPITAL OF TEXASTX252$435.4M67.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $9.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.8M+210bp18mo
Cost to Collect4.5%2.5%$2.6M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.6M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.6M+122bp9mo
Clean Claim Rate88.0%96.0%$84K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.8M
Cost to Collect
$2.6M
Denial Rate Reduction
$2.6M
A/R Days Reduction
$1.6M
Clean Claim Rate
$84K
Total EBITDA Uplift$9.6M
Current EBITDA$6.3M
+ RCM Uplift+$9.6M
Pro Forma EBITDA$15.9M
Current Margin4.8%
Pro Forma Margin12.2%
WC Released (1x)$5.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$9.7M$138.0M14.24x70.1%
Base (11x exit)10.0x11.0x$9.7M$154.9M15.99x74.1%
Bull Case9.0x11.0x$8.7M$189.9M21.78x85.2%
Bull (12x exit)9.0x12.0x$8.7M$209.7M24.05x88.9%
Bear Case11.0x10.0x$10.7M$86.6M8.13x52.0%
Bear (11x exit)11.0x11.0x$10.7M$98.7M9.26x56.1%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 173 hospitals with 66-262 beds
  • Same-state prioritization (n=174)
  • Comp margins: P25=-8.8% / P50=2.4% / P75=13.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.